[HTML][HTML] Use of tocilizumab and sarilumab alone or in combination with corticosteroids for covid-19: systematic review and network meta-analysis
D Zeraatkar, E Cusano, JPD Martínez, A Qasim… - BMJ …, 2022 - ncbi.nlm.nih.gov
Use of tocilizumab and sarilumab alone or in combination with corticosteroids for covid-19:
systematic review and network meta-analysis - PMC Back to Top Skip to main content NIH …
systematic review and network meta-analysis - PMC Back to Top Skip to main content NIH …
Efficacy and safety of IL-6 inhibitors in patients with COVID-19 pneumonia: a systematic review and meta-analysis of multicentre, randomized trials
A Belletti, C Campochiaro, M Marmiere… - Annals of Intensive …, 2021 - Springer
Purpose COVID-19 is characterized by dysregulated immune response, respiratory failure
and a relevant mortality rate among hospitalized patients. Interleukin-6 (IL-6) is involved in …
and a relevant mortality rate among hospitalized patients. Interleukin-6 (IL-6) is involved in …
Japanese rapid/living recommendations on drug management for COVID‐19: updated guidelines (September 2021)
K Yamakawa, R Yamamoto, T Terayama… - Acute Medicine & …, 2021 - Wiley Online Library
Background The coronavirus disease 2019 (COVID‐19) has spread worldwide since early
2020, and there are still no signs of resolution. The Japanese Clinical Practice Guidelines …
2020, and there are still no signs of resolution. The Japanese Clinical Practice Guidelines …
COVID-19 therapies for inpatients: a review and quality assessment of clinical guidelines
DA Wohl, AA Espinueva, L Dau, CY Wang… - ERJ Open …, 2022 - Eur Respiratory Soc
Owing to condensed development processes, expanding evidence and differences in
healthcare system characteristics, many COVID-19 guidelines differ in their quality and …
healthcare system characteristics, many COVID-19 guidelines differ in their quality and …
Japanese rapid/living recommendations on drug management for COVID‐19: updated guidelines (July 2022)
K Yamakawa, R Yamamoto, T Terayama… - Acute Medicine & …, 2022 - Wiley Online Library
Background Coronavirus disease (COVID‐19), an infectious disease caused by the novel
coronavirus severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has spread …
coronavirus severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has spread …
Tocilizumab in COVID-19–A Bayesian reanalysis of RECOVERY
Abstract Background Randomised Evaluation of COVID-19 Therapy (RECOVERY)
demonstrated that tocilizumab reduces mortality in hospitalized COVID-19 patients …
demonstrated that tocilizumab reduces mortality in hospitalized COVID-19 patients …
Real-world Evidence and Network Meta-analysis for the Effectiveness of Remdesivir and Tocilizumab for Hospitalised Patients with COVID-19
C Read - 2023 - studenttheses.uu.nl
The COVID-19 pandemic and the strain it placed on healthcare systems highlighted a key
role for real-world data in quickly generating health evidence. A growing demand for large …
role for real-world data in quickly generating health evidence. A growing demand for large …